Deep Vein Thrombosis (DVT)

 Deep Vein Thrombosis (DVT) : Note For Doctors

• Deep Vein Thrombosis (DVT): The formation of a thrombus (blood clot) within the deep veins, most commonly in the lower extremities. If untreated, it can lead to severe complications such as pulmonary embolism (PE).

Pathophysiology:

• Virchow’s Triad: Three key factors contributing to thrombogenesis:
  • Stasis of blood flow (e.g., immobility, prolonged sitting, heart failure)
  • Endothelial injury (e.g., trauma, surgery, catheter insertion)
  • Hypercoagulability (e.g., genetic disorders like Factor V Leiden, malignancy, pregnancy)
• Clot formation begins when platelets adhere to the endothelial surface, followed by fibrin deposition and aggregation of blood cells. The clot can extend, causing venous obstruction.

virchows triad

Etiology and Risk Factors:

• Primary Risk Factors:
  • Prolonged immobility (post-surgery, prolonged bed rest, long-duration travel)
  • Surgical procedures (especially orthopedic surgeries: hip, knee)
  • Trauma (fractures, surgery, etc.)
  • Malignancy (increased clotting tendency due to tumor-derived procoagulants)
  • Pregnancy and postpartum (due to increased estrogen levels and venous stasis)
  • Oral contraceptives and hormone replacement therapy (estrogen increases clotting risk)
  • Genetic thrombophilia (e.g., Factor V Leiden mutation, Prothrombin gene mutation)
• Secondary Risk Factors:
  • Age > 60 years
  • Obesity
  • Family history of DVT or PE
  • Smoking
  • Chronic conditions like heart failure, varicose veins, and inflammatory bowel disease.

Clinical Presentation:

• Common Symptoms:
  • Unilateral leg swelling: Most common clinical feature, often with a sense of heaviness.
  • Pain: Deep, aching pain in the affected leg, aggravated by standing or walking.
  • Erythema: Redness and warmth over the affected area.
  • Palpable cord: The thrombus may feel like a firm, rope-like structure along the affected vein.
• Classic Signs:
• Homan’s sign: Pain on dorsiflexion of the foot (not highly sensitive or specific).
• Positive Homans or Lowenberg test: Pain with calf compression, though less commonly used in modern clinical practice.

Complications:

• Pulmonary Embolism (PE): The most serious complication. Clots from DVT may dislodge and travel to the pulmonary circulation, causing a blockage.
• Post-thrombotic Syndrome (PTS): Chronic condition resulting from long-term venous hypertension, causing pain, swelling, and skin changes.
• Chronic Venous Insufficiency: Due to damage to venous valves, leading to chronic swelling and skin changes.

Diagnosis:

1. Clinical Assessment:

   • Clinical probability can be assessed using the Wells score (for DVT and PE), which factors in risk factors and clinical presentation.

2. Ultrasound (Doppler):

   • The gold standard for diagnosing DVT. High-frequency ultrasound assesses for the presence of a thrombus, venous compression, and blood flow.

3. D-dimer:

   • Elevated D-dimer levels indicate fibrin degradation products, suggesting clot formation. However, it lacks specificity, and can be raised in other conditions (e.g., infection, cancer).
   • Sensitivity >95%, but specificity is low, especially in low-risk patients.

4. CT Venography/Magnetic Resonance Venography (MRV):

   • Used in selected cases when ultrasound is inconclusive or inaccessible.

5. Contrast Venography:

   • The gold standard historically but is less commonly used today due to its invasiveness and the rise of ultrasound.

Management:

1. Anticoagulation Therapy:

   • Initial Treatment:
     • Low molecular weight heparin (LMWH) (e.g., enoxaparin) or unfractionated heparin (UH) for immediate anticoagulation.
     • Direct oral anticoagulants (DOACs) (e.g., rivaroxaban, apixaban) as an alternative to LMWH.
   • Long-term Management:
     • Warfarin (Coumadin), INR monitored (goal INR 2.0-3.0), or continued use of DOACs for 3-6 months based on risk factors and the nature of the clot.

2. Thrombolysis:

   • Recombinant tissue plasminogen activator (rt-PA) or urokinase for large, symptomatic clots or in cases with life-threatening PE. Reserved for severe cases.

3. Thrombectomy or Catheter-directed Thrombolysis:

   • Surgical intervention or catheter-based removal may be considered in patients with massive DVT or failure of anticoagulation therapy.

4. Inferior Vena Cava (IVC) Filter:

• Used in patients with contraindications to anticoagulation (e.g., active bleeding) or recurrent PE despite anticoagulation therapy.
• 

Compression Stockings:

• Used to reduce swelling, prevent post-thrombotic syndrome, and improve venous return in chronic cases.

Prevention:

• Prophylaxis:
  • Early mobilization and exercises for hospitalized patients.
  • Low-dose heparin or LMWH for high-risk surgical patients.
  • Intermittent pneumatic compression devices for critically ill patients.
  • Compression stockings for those at risk, especially post-operatively.

Follow-up and Monitoring:

• Regular monitoring of anticoagulation levels, especially for warfarin (INR monitoring), and for signs of bleeding complications.
• For patients on DOACs, renal function should be monitored periodically.